ArticleCancer2016

Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.

Daria Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.